Consolidated Statement Of Income

OncoTherapy Science, Inc. - Filing #7714893

Concept 2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
Consolidated statement of income
Statement of income
Net sales
247,868,000 JPY
JPY
44,692,000 JPY
247,868,000 JPY
203,176,000 JPY
Operating expenses
Selling, general and administrative expenses
222,144,000 JPY
205,271,000 JPY
Operating expenses
Net sales
Operating profit (loss)
-2,146,027,000 JPY
-171,997,000 JPY
-645,439,000 JPY
-1,974,029,000 JPY
-1,328,590,000 JPY
-2,217,301,000 JPY
Ordinary profit (loss)
-2,152,706,000 JPY
-2,215,476,000 JPY
Operating expenses
Research and development expenses
2,171,752,000 JPY
2,215,215,000 JPY
Non-operating income
Interest income
520,000 JPY
910,000 JPY
Non-operating income
843,000 JPY
1,849,000 JPY
Extraordinary income
26,156,000 JPY
57,914,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Non-operating expenses
7,521,000 JPY
24,000 JPY
Profit (loss) before income taxes
-2,126,549,000 JPY
-2,157,561,000 JPY
Extraordinary income
Income taxes - current
4,115,000 JPY
3,523,000 JPY
Income taxes - deferred
-1,227,000 JPY
7,107,000 JPY
Income taxes
2,887,000 JPY
10,631,000 JPY
Profit (loss)
-2,129,436,000 JPY
-2,168,192,000 JPY
Profit (loss) attributable to non-controlling interests
-234,908,000 JPY
-21,442,000 JPY
Profit (loss) attributable to owners of parent
-1,894,527,000 JPY
-2,146,749,000 JPY
Profit attributable to
Other comprehensive income
Foreign currency translation adjustment
288,000 JPY
-1,183,000 JPY
Other comprehensive income
288,000 JPY
-1,183,000 JPY
Comprehensive income
-2,129,148,000 JPY
-2,169,376,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,894,239,000 JPY
-2,147,933,000 JPY
Comprehensive income attributable to non-controlling interests
-234,908,000 JPY
-21,442,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.